American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $45.4M | 0.05% |
1,374,913
+135,140
| +11% | +$4.57M |
|
|
LOGM
352
DELISTED
LogMein, Inc.
LOGM
| $45.4M | 0.05% |
639,381
+32,561
| +5% | +$2.33M |
|
353
Cognex
CGNX
$10.3B
| $44.8M | 0.04% |
911,253
-6,198
| -0.7% | -$280K |
|
|
STOR
354
DELISTED
STORE Capital Corporation
STOR
| $44.4M | 0.04% |
1,187,548
-101,219
| -8% | -$3.62M |
|
355
Murphy USA
MUSA
$10.2B
| $44.2M | 0.04% |
518,296
+122,794
| +31% | +$10.8M |
|
356
HEICO Corp
HEI
$51.4B
| $44.1M | 0.04% |
353,054
+350,198
| +12,262% | +$47.9M |
|
357
Spectrum Brands
SPB
$2.07B
| $43.8M | 0.04% |
831,490
+244,025
| +42% | +$12.7M |
|
358
Agree Realty
ADC
$9.32B
| $43.6M | 0.04% |
595,417
-8,848
| -1% | -$618K |
|
359
Allison Transmission
ALSN
$10.1B
| $43.1M | 0.04% |
915,548
-118,480
| -11% | -$5.37M |
|
360
Devon Energy
DVN
$48.6B
| $43M | 0.04% |
1,785,818
-2,792,387
| -61% | -$69.9M |
|
|
BLUE
361
DELISTED
bluebird bio
BLUE
| $42.5M | 0.04% |
35,706
-4,651
| -12% | -$7.1M |
|
362
Tetra Tech
TTEK
$9.08B
| $41.9M | 0.04% |
2,416,350
+1,714,295
| +244% | +$28M |
|
363
Teradata
TDC
$2.48B
| $41.1M | 0.04% |
1,327,302
+61,502
| +5% | +$2.08M |
|
|
VAR
364
DELISTED
Varian Medical Systems, Inc.
VAR
| $40.8M | 0.04% |
342,859
+24
| +0% | +$2.85K |
|
365
Donaldson
DCI
$11.1B
| $40.7M | 0.04% |
781,352
+152
| +0% | +$7.52K |
|
366
Insulet
PODD
$9.98B
| $40.6M | 0.04% |
246,125
-198,444
| -45% | -$27.9M |
|
367
Bio-Techne
TECH
$11.3B
| $39.9M | 0.04% |
816,040
-68,852
| -8% | -$3.45M |
|
368
IBM
IBM
$220B
| $39.4M | 0.04% |
283,073
+133
| +0% | +$17.9K |
|
369
Akamai
AKAM
$17.8B
| $38.9M | 0.04% |
425,657
-476,361
| -53% | -$41.3M |
|
370
Waters Corp
WAT
$40.8B
| $38.4M | 0.04% |
172,056
-5,190
| -3% | -$1.12M |
|
371
Timken Company
TKR
$9.1B
| $38.1M | 0.04% |
876,685
+150,210
| +21% | +$6.64M |
|
|
AMED
372
DELISTED
Amedisys
AMED
| $37.9M | 0.04% |
289,581
-106,285
| -27% | -$13.8M |
|
|
AGN
373
DELISTED
Allergan plc
AGN
| $37.9M | 0.04% |
225,392
-397,870
| -64% | -$64.8M |
|
374
Icon
ICLR
$12.8B
| $37.4M | 0.04% |
254,050
-1,640
| -0.6% | -$252K |
|
375
Halliburton
HAL
$27.5B
| $37.2M | 0.04% |
1,972,019
-323,680
| -14% | -$6.7M |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.